Toggle light / dark theme

This is actually an addition to Genevieve’s post on CubeSat.


Humans are returning to the Moon for the first time in decades, and we intend to stay. NASA’s Artemis missions are preparing for a sustained human presence on and around the Moon, with the ultimate goal of sending humans to Mars. These deep-space destinations present health risks to astronauts that are qualitatively and quantitatively different from those associated with stays on the International Space Station (ISS). One of the most significant risks for astronauts venturing outside the protection of Earth’s magnetic field is ionizing radiation: Galactic Cosmic Rays (GCR), Solar Particle Events (SPE), and the “albedo” radiation produced by the interaction of space radiation with the lunar surface. Exposure to ionizing radiation can result in an increased risk of cancer, cardiovascular disease, and neurological impairment.

Hi folks, I’d like to invite you to a webinar I will be giving on my research, hosted by the Foresight Institute! It takes place this Friday at 12:00pm CST. You can sign up on the linked page. The donation is optional, so if you don’t want to donate, you can just put $0.00. I hope to see you there!


Biotech and Health Extension sponsored by 100 Plus Capital

Viruses inside vaults: a powerful new gene therapy delivery system

Bio: Logan Thrasher Collins is a synthetic biologist, author, and futurist. He is currently a PhD candidate in biomedical engineering at Washington University in St. Louis. Logan began engaging in scientific research during his sophomore year of high school when he created a new synthetic biology approach for combatting antibiotic resistant infections. Since then, he has led research projects on developing x-ray microscopy techniques for connectomics, using molecular dynamics simulations to study SARS-CoV-2, and inventing novel gene therapy delivery systems. Logan has spoken at TEDxMileHigh and has published peer-reviewed scientific papers on his research. He has also published science fiction and sci-fi poetry and as well as a peer-reviewed philosophy journal article. Logan passionately advocates for applying interdisciplinary solutions to global challenges and leverages both the arts and sciences to help build a bright future.

Scientists have developed microscopic robots capable of treating brain aneurysms with unprecedented precision, offering a potential alternative to invasive brain surgeries. An international team, including researchers from the University of Edinburgh, engineered these nanorobots to safely and accurately deliver life-saving medications to the brain. This advancement comes in the context of a global health challenge, […].

This was created by a company called Xenex a decade ago In San Antonio Texas, where I used to live.


JOINT BASE LANGLEY-EUSTIS, Va. (AFNS) — Standing at 5 feet 2 inches tall, U.S. Air Force Hospital Langley’s newest staff member doesn’t initially have a commanding presence; however, after five minutes, its impact has the potential to save countless lives around the world.

The 633rd Medical Group received a germ-zapping robot, nicknamed “Saul,” which harnesses the power of technology to kill off viruses — including the Ebola virus. Airmen were given a demonstration of the robots functions and capabilities from Geri Genant, the Xenex Healthcare Services implementation manager.

Shortly after the president issued an executive order addressing the critical issue of Ebola, the 633rd MDG responded with cutting-edge technology to protect the health of the service members, their families and the community.

The SARS-CoV-2 pandemic has had an unprecedented impact on global public health and the economy. Although vaccines and antivirals have provided effective protection and treatment, the development of new small molecule-based antiviral candidates is imperative to improve clinical outcomes against SARS-CoV-2. In this study, we identified UNI418, a dual PIKfyve and PIP5K1C inhibitor, as a new chemical agent that inhibits SARS-CoV-2 entry into host cells. UNI418 inhibited the proteolytic activation of cathepsins, which is regulated by PIKfyve, resulting in the inhibition of cathepsin L-dependent proteolytic cleavage of the SARS-CoV-2 spike protein into its mature form, a critical step for viral endosomal escape. We also demonstrated that UNI418 prevented ACE2-mediated endocytosis of the virus via PIP5K1C inhibition. Our results identified PIKfyve and PIP5K1C as potential antiviral targets and UNI418 as a putative therapeutic compound against SARS-CoV-2.

Despite the ongoing threat posed by new viruses following the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which led to the coronavirus disease 2019 (COVID-19) pandemic, new antiviral drugs continue to be developed to effectively block viral entry into the human body.

Professor Kyungjae Myung and his research team in the Department of Biomedical Engineering, affiliated with the IBS Center for Genomic Integrity, has discovered UNI418, a compound that effectively prevents the penetration of the coronavirus. This compound works by regulating dielectric homeostasis, thereby inhibiting the virus’s entry into human cells.

Question Can microplastics reach the olfactory bulb in the human brain?

Findings This case series analyzed the olfactory bulbs of 15 deceased individuals via micro-Fourier transform infrared spectroscopy and detected the presence of microplastics in the olfactory bulbs of 8 individuals. The predominant shapes were particles and fibers, with polypropylene being the most common polymer.

Meaning The presence of microplastics in the human olfactory bulb suggests the olfactory pathway as a potential entry route for microplastics into the brain, highlighting the need for further research on their neurotoxic effects and implications for human health.

How can machine learning help individuals with type 1 diabetes (T1D)? This is what a study presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) hopes to address as a team of researchers have developed a system using machine learning capable of managing blood sugars levels with such proficiency that those using system were able to lead lives far more active than the average T1D patient.

For the study, the researchers developed the AID system, which uses closed-loop technology that delivers insulin based on readings from the machine learning algorithm, resulting in a 50-year-old man, a 40-year-old man, and a 34-year-old woman with T1D being able to run hours-long marathons in Tokyo, Santiago, and Paris, respectively. This study holds the potential to help develop better technology capable of allowing T1D diabetes patients to stay in shape without constantly fearing for their blood sugar levels, which can lead to long-term health problems, including hyperglycemia, nerve damage, or a heart attack.

“Despite better systems for monitoring blood sugars and delivering insulin, maintaining glucose levels in target range during aerobic training and athletic competition is especially difficult,” said Dr. Maria Onetto, who is in the Department of Nutrition at the Pontifical Catholic University of Chile and lead author of the study. “The use of automated insulin delivery technology is increasing, but exercise continues to be a challenge for individuals with T1D, who can still struggle to reach the recommended blood sugar targets.”

A new study has uncovered significant differences in how male and female mice process threats, even as they exhibit similar behavioural responses. The discovery suggests that including both male and female subjects in neuroscience research will lead to more accurate conclusions and ultimately better health outcomes. Understanding the influence of sex on brain function can help explain why males and females develop certain psychiatric disorders at different rates or with different symptoms, the researchers said. ‘Unless we thoughtfully and rigorously integrate sex into biomedical research, a huge amount of the population may be underserved by scientific knowledge,’ said McGill University Associate Professor and Canada Research Chair in Behavioural Neurogenomics Rosemary Bagot, who led the study. ‘Our work shows that sex is an important variable to consider, even if initial observations don’t necessarily show clear sex differences,” said Bagot. “If males and females are using different brain circuits to solve similar problems, they may be differently vulnerable to stress and respond differently to treatments.’ How brain circuits process threats and cues The study focused on two related brain circuits and their roles in processing information about threats and the cues that predict them. The researchers trained mice to recognize a sound that signalled a threat and another sound that meant safety. By observing brain activity, the team saw how communication between different brain areas processed these signals. Then, they temporarily turned off each brain connection to see how it affected the mice’s reactions, helping them understand how the brain handles threats. ‘We found that even though male and female mice respond similarly to threats, the brain circuits underlying these responses are not the same,’ Bagot said. For female mice, a connection between two specific brain areas (the medial prefrontal cortex and the nucleus accumbens) played a key role. The study found that in male mice, a different connection (between the ventral hippocampus and the nucleus accumbens) was more important for handling the same situation. It was previously assumed that similar behavior meant similar brain function. Now, the researchers are exploring how sex impacts brain circuits in processing threats, focusing on the role of sex hormones and different learning strategies. This research is supported by funding from CIHR. About the study Sex-biased neural encoding of threat discrimination in nucleus accumbens afferents drives suppression of reward behavior by Jessie Muir, Eshaan Iyer et al., was published in Nature Neuroscience.